Niels Peter Hundahl Møller

Author

Also Known As

N MOLLER, N P H Møller, N P Møller, N P møller, N. P. H. Moller, N. P. H. MØLLER, N. P. H. Møller, N. P. Hundahl Møller, N.P. Hundahl Møller, N.P. Moller

Publications

6.3K

Citations

H-Index

105

Concepts

All Affiliations

Novo Nordisk (Denmark)Technical University of Denmark Max Planck Institute of Biochemistry Aarhus University

About

Niels Peter Hundahl Møller is an author at Novo Nordisk (Denmark) specializing in medicine, biochemistry, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	3.3K
2	Natural Sciences	13	13	764
3	Allergy	6	6	180
4	Engineering	3	3	126
5	Public Health	2	2	23

Niels Peter Hundahl Møller

Publications

4.8K

Citations

H-Index

Page 1

	Year	Citations
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis B Millauer, Susanne Wizigmann-Voos, Harald Schnürch, Cell Developmental BiologyAngiogenesisReceptor Tyrosine KinaseDevelopmental ExpressionMajor Regulator	1993	1.9K
ERK6, a mitogen-activated protein kinase involved in C2C12 myoblast differentiation. Christian Lechner, Muayad A. Zahalka, Jean-François Giot, Proceedings of the National Academy of Sciences Wild-type Erk6Cellular PhysiologySignaling PathwayCell RegulationReceptor Tyrosine Kinase	1996	328
Structure-based Design of a Low Molecular Weight, Nonphosphorus, Nonpeptide, and Highly Selective Inhibitor of Protein-tyrosine Phosphatase 1B Lars Iversen, Henrik Sune Andersen, Sven Branner, Journal of Biological Chemistry Ptp1b Knockout MiceLow Molecular WeightBiochemistryRemarkable SelectivityNatural Sciences	2000	173
Structure Determination of T Cell Protein-tyrosine Phosphatase Lars Iversen, Karin Möller, Anja K. Pedersen, Journal of Biological Chemistry	2002	172
An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma Ian D. Davis, Birte K. Skrumsager, Jonathan Cebon, Clinical Cancer Research	2007	164
The ligand specificities of the insulin receptor and the insulin-like growth factor I receptor reside in different regions of a common binding site. Thomas Kjeldsen, Asser S. Andersen, Finn C. Wiberg, Proceedings of the National Academy of Sciences Systems BiologySignal TransductionMolecular PhysiologyBiochemistryG Protein-coupled Receptor	1991	140
Characterization of KIF1C, a New Kinesin-like Protein Involved in Vesicle Transport from the Golgi Apparatus to the Endoplasmic Reticulum Cornelia Dorner, Thomas Ciossek, Susanne Müller, Journal of Biological Chemistry	1998	139
Discovery and SAR of a Novel Selective and Orally Bioavailable Nonpeptide Classical Competitive Inhibitor Class of Protein-Tyrosine Phosphatase 1B Henrik Sune Andersen, Ole H. Olsen, Lars Iversen, Journal of Medicinal Chemistry Drug TargetSelective Ptp1b InhibitorsProtein-tyrosine Phosphatase 1BChemical BiologyMedicinal Chemistry	2002	131
Mechanism of protein tyrosine phosphatase 1B-mediated inhibition of leptin signalling Ida Katrine Lund, Henrik Sune Andersen, Niels Peter Hundahl Møller, Journal of Molecular Endocrinology	2005	131
2-(Oxalylamino)-Benzoic Acid Is a General, Competitive Inhibitor of Protein-tyrosine Phosphatases Henrik Sune Andersen, Lars Iversen, Claus Jeppesen, Journal of Biological Chemistry	2000	119

Page 1